Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma AR Meneghetti, A Zwanenburg, S Leger, K Leger, EGC Troost, A Linge, ... Clinical and Translational Radiation Oncology, 2020 | 10 | 2020 |
Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC A Rabasco Meneghetti, A Zwanenburg, A Linge, F Lohaus, M Grosser, ... Scientific Reports 12 (1), 16755, 2022 | 7 | 2022 |
A Good Feature Extractor Is All You Need for Weakly Supervised Learning in Histopathology G Wölflein, D Ferber, AR Meneghetti, OSM El Nahhas, D Truhn, ... arXiv preprint arXiv:2311.11772, 2023 | 2 | 2023 |
Pictures worth more than a thousand words: Prediction of survival in medulloblastoma patients AR Meneghetti, A Zwanenburg, S Löck EBioMedicine 62, 2020 | 2 | 2020 |
Assessing microsatellite instability dominance in colorectal cancer phenotype: A multi-study initiative using multi-target transformers for genomic biomarker prediction M Gustav, M van Treeck, ZI Carrero, CM Loeffler, NG Reitsam, B Märkl, ... Cancer Research 84 (6_Supplement), 4924-4924, 2024 | | 2024 |
MO-0725 Radiomics-based prediction of radiosensitivity from preclinical HNSCC histopathology imageS S Michlikova, AR Meneghetti, S Lock, A Yakimovich, T Rassamegevanon, ... Radiotherapy and Oncology 182, S593, 2023 | | 2023 |
OC-0638 Integrated radiogenomics analyses for outcome prognosis in patients with locally advanced HNSCC A Rabasco, A Zwanenburg, A Linge, F Lohaus, M Grosser, G Baretton, ... Radiotherapy and Oncology 161, S503-S504, 2021 | | 2021 |
Radiomic models for validation in patients with locally advanced HNSCC treated with primary RTCx A Rabasco, A Zwanenburg, S Leger, K Pilz, F Lohaus, A Linge, K Zöphel, ... Radiotherapy and Oncology 152, S832-S833, 2020 | | 2020 |
Clinical and Translational Radiation Oncology AR Meneghetti, A Zwanenburg, S Leger, K Leger, EGC Troost, A Linge, ... | | |